Immatics Stock (NASDAQ: IMTX) stock price, news, charts, stock research, profile.
You can purchase shares of Immatics (NASDAQ:IMTX) through any online brokerage.
Other companies in Immatics’s space includes: Immunome (NASDAQ:IMNM), ARS Pharmaceuticals (NASDAQ:SPRY), 89bio (NASDAQ:ETNB), Gyre Therapeutics (NASDAQ:GYRE) and Upstream Bio (NASDAQ:UPB).
Immatics has a consensus price target of $20.20.
The stock price for Immatics (NASDAQ: IMTX) is $7.21 last updated December 13, 2024 at 4:39 PM EST.
There are no upcoming dividends for Immatics.
Immatics’s Q3 earnings are confirmed for Monday, November 18, 2024.
There is no upcoming split for Immatics.
Immatics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.